Human purinergic P2U receptor
US6479630B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Jun 22, 1998 |
| Grant date | Nov 12, 2002 |
| Priority date | — |
| Expiry date | Jun 22, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides nucleotide and amino acid sequences that identify and encode a novel purinergic PU2 receptor (PNR) expressed in human placenta. The present invention also provides for antisense molecules to the nucleotide sequences which encode PNR, expression vectors for the production of purified PNR, antibodies capable of binding specifically to PNR, hybridization probes or oligonucleotides for the detection of PNR-encoding nucleotide sequences, genetically engineered host cells for the expression of PNR, and diagnostic tests based on PNR-encoding nucleic acid molecules or antibodies produced against the polypeptide PNR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.